The Immunophenotyping laboratory performs a range of tests as detailed below:
|
HMDS Immunophenotyping Malignancy Investigations |
|||
|
Known or Suspected Diagnosis |
Panel |
Sample Requirements |
Turnaround Time |
|
ALL |
9ml EDTA bone marrow; 4.5ml EDTA peripheral blood |
14 days |
|
|
AML |
Acute panel |
9ml EDTA bone marrow; 4.5ml EDTA peripheral blood |
14 days |
|
Aplastic Anaemia |
4.5ml EDTA peripheral blood |
14 days |
|
|
CLL |
4.5ml EDTA peripheral blood |
14 days |
|
|
Lymphomas |
CLL/lymphoma panel |
9ml EDTA bone marrow; 4.5ml EDTA peripheral blood, lymph nodes |
14 days |
|
CML |
Not indicated |
||
|
MDS |
Not indicated |
||
|
Myeloma |
Not indicated |
||
|
Myeloproliferative Neoplasms: |
Not indicated |
||
|
Polycythemia Vera |
Not indicated |
||
|
Essential Thrombocythemia |
Not indicated |
||
|
Myelofibrosis |
Not indicated |
||
|
Eosinophilia |
Not indicated |
||
|
HMDS Immunophenotyping Immune Monitoring |
|||
|
Please note that all samples must be received within 48 hours of being collected |
|||
|
Panel |
Sample Requirements |
Turnaround Time |
|
|
Lymphocyte Subsets |
4.5ml EDTA peripheral blood |
48 hours |
|
|
Lymphocyte Subsets |
4.5ml EDTA peripheral blood |
48 hours |
|
|
Rituximab Monitoring |
4.5ml EDTA peripheral blood |
48 hours |
|